Blood thinner trombix under Real-World review for heart rhythm disorder
Disease control
Completed
This completed study in Algeria followed 398 adults with atrial fibrillation who were taking the blood thinner Trombix (Rivaroxaban). The goal was to see how safe and effective the drug is in everyday medical practice, and how it affects quality of life. Researchers tracked serio…
Sponsor: Beker Laboratories • Aim: Disease control
Last updated Jun 26, 2026 18:52 UTC